DAL FERRO, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 4.647
NA - Nord America 4.452
AS - Asia 3.708
SA - Sud America 469
AF - Africa 123
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.417
Nazione #
US - Stati Uniti d'America 4.321
IT - Italia 1.955
SG - Singapore 1.262
CN - Cina 937
PL - Polonia 696
DE - Germania 390
VN - Vietnam 379
BR - Brasile 355
HK - Hong Kong 283
GB - Regno Unito 261
BD - Bangladesh 259
FR - Francia 243
NL - Olanda 226
KR - Corea 200
SE - Svezia 195
FI - Finlandia 167
RU - Federazione Russa 113
IN - India 96
CA - Canada 74
IE - Irlanda 67
CH - Svizzera 57
ES - Italia 57
MA - Marocco 48
BG - Bulgaria 47
AR - Argentina 45
JP - Giappone 45
AT - Austria 43
TR - Turchia 42
ID - Indonesia 38
MX - Messico 34
UA - Ucraina 31
ZA - Sudafrica 27
GR - Grecia 23
IQ - Iraq 20
CL - Cile 16
PK - Pakistan 16
AU - Australia 15
EG - Egitto 15
EC - Ecuador 14
SA - Arabia Saudita 13
TW - Taiwan 13
CZ - Repubblica Ceca 11
BE - Belgio 10
PY - Paraguay 10
CO - Colombia 9
JO - Giordania 9
PH - Filippine 9
RO - Romania 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
AL - Albania 7
IL - Israele 7
NP - Nepal 7
TH - Thailandia 7
AZ - Azerbaigian 6
KE - Kenya 6
KZ - Kazakistan 6
LV - Lettonia 6
UY - Uruguay 6
UZ - Uzbekistan 6
GE - Georgia 5
IR - Iran 5
MY - Malesia 5
PT - Portogallo 5
BY - Bielorussia 4
DZ - Algeria 4
KG - Kirghizistan 4
LB - Libano 4
RS - Serbia 4
SN - Senegal 4
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LK - Sri Lanka 3
LT - Lituania 3
OM - Oman 3
PE - Perù 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
BZ - Belize 2
CY - Cipro 2
GA - Gabon 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BF - Burkina Faso 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 13.395
Città #
Singapore 723
Ashburn 672
Warsaw 627
San Jose 378
Trieste 306
Chandler 276
Hong Kong 265
Hefei 200
Milan 195
Beijing 191
Seoul 189
Dallas 186
Fairfield 170
Munich 169
Council Bluffs 154
Los Angeles 146
Chicago 124
Ho Chi Minh City 120
Woodbridge 120
Rome 109
Seattle 103
Helsinki 98
New York 97
Boardman 94
Cambridge 87
London 85
Wilmington 84
Houston 83
Hanoi 76
Santa Clara 70
Turin 68
Lauterbourg 67
Ann Arbor 65
Dublin 63
Zgierz 56
Frankfurt am Main 52
Princeton 49
Columbus 48
Amsterdam 47
Sofia 46
Buffalo 44
Moscow 43
São Paulo 43
Venice 43
Casablanca 41
Bologna 39
Shanghai 38
Bern 35
Phoenix 35
The Dalles 34
Florence 32
Lappeenranta 32
Orem 32
Da Nang 31
Vienna 31
Redmond 29
Nuremberg 28
Denver 26
Turku 26
Düsseldorf 25
Montreal 25
Jacksonville 23
Redondo Beach 23
Udine 23
Tokyo 22
Naples 21
Genoa 20
Toronto 20
Bremen 19
Guangzhou 19
Palermo 19
Atlanta 18
Chennai 18
Padova 18
Paris 18
Dearborn 16
Dong Ket 16
Memphis 16
Mumbai 16
Poplar 16
Athens 15
Salt Lake City 15
Brooklyn 14
Dhaka 14
Jakarta 14
Utrecht 14
Boydton 13
Grafing 13
Izmir 13
Jinan 13
Pescara 13
Washington 13
Berlin 12
Elk Grove Village 12
Istanbul 12
Pune 12
Shenzhen 12
Stockholm 12
Catania 11
Edinburgh 11
Totale 8.089
Nome #
Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library 716
Il Registro Regionale delle Morti Cardiache Improvvise in età giovanile del Friuli Venezia Giulia. Protocolli operativi e risultati di un progetto multidisciplinare 631
AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia 530
Cardiac fluid dynamics meets deformation imaging 480
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 408
Facciamo il punto: miocardio non compatto 382
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 358
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy 340
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 310
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking 303
In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells 262
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives 255
Terapia di modulazione della contrattilità cardiaca: basi molecolari e razionale per l’impiego in modelli di insufficienza cardiaca sistolica e diastolica 254
Genetics of Dilated Cardiomyopathy: Clinical Implications 247
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 227
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 224
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 219
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 219
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 214
Role of the Electrocardiogram in Differentiating Genetically Determined Dilated Cardiomyopathy from Athlete's Heart 213
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy 199
Echocardiographic evaluation of centenarians in Trieste 195
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 192
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 192
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 186
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies 183
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 180
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy 175
Preserved skeletal muscle mitochondrial function, redox state, inflammation and mass in obese mice with chronic heart failure 172
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 170
Myocarditis: Which Role for Genetics? 170
Cardiomyopathies in children: Classification, diagnosis and treatment 168
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 163
Prognostic role of exercise intensity in familial Filamin C truncating variants 155
n-3 PUFA-Enriched Diet Preserves Skeletal Muscle Mitochondrial Function and Redox State and Prevents Muscle Mass Loss in Mice with Chronic Heart Failure 154
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 152
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management 151
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry. 148
Cardiology of the future: xenotransplantation with porcine heart 146
Lymphocytic Myocarditis: A Genetically Predisposed Disease? 142
Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction 139
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 138
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 135
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases 135
The Arrhythmic Phenotype in Cardiomyopathy 134
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 132
Genetic testing in cardiomyopathies: updates and future perspectives 130
Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation 125
Sport and Exercise in Genotype positive (+) Phenotype negative (-) Individuals. Current Dilemmas and Future Perspectives 124
Exercise Intensity and Cardiac Disease Development in carriers of Titin variants 120
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy 118
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function 118
Generation of iPSC lines (ICHi001-A, ICHi002-A, ICHi003-A, ICHi004-A) from four patients carrying Titin truncating variants associated with dilated cardiomyopathy 117
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 116
A European Delphi Consensus on the Management of Abdominal Aortic Aneurysms in Patients with Heritable Aortic Diseases 115
Heart failure with reduced ejection fraction and monogenic dilated cardiomyopathy: distinct diseases? Insights from randomized controlled trials 110
The contribution of cardiopulmonary exercise testing in the familial screening for dilated and non-dilated left ventricular cardiomyopathies: case series 99
Lamin A/C Cardiomyopathy: Cutting Edge to Personalized Medicine 99
Genetic tracing and topography of spontaneous and stimulated cardiac regeneration in mice 95
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score 93
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 92
Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification 91
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 85
Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease 84
Enhanced prognostic value of four‐tier hybrid grading system in Ta non‐muscle‐invasive bladder cancer 81
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 73
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy 70
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants 70
Titin Cardiomyopathy, Emerging Evidence: More Than A Big Heart 69
The heart of dystrophinopathies 66
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 60
Unveiling the spectrum of sudden cardiac death: a multidisciplinary analysis from the Friuli Venezia Giulia registry 56
Long-term outcomes and predictors of mortality in patients with chronic ischemic left ventricular dysfunction undergoing PCI: A multicenter study 54
Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy 51
Mechanical load inhibits cancer growth in mouse and human hearts 43
What Should a Clinical Cardiologist Know About Cardiogenetics? 34
Predictors of Disease Progression in Patients with Left Ventricular Non-Dilated Cardiomyopathy 29
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 21
Classification of cardiomyopathies: bringing order to complexity 16
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants 9
RBM20 Truncating Variants and Human Cardiomyopathy 8
Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: a multicenter retrospective landmark analysis 6
Polygenic risk in early-onset coronary artery disease with low prevalence of traditional cardiovascular risk factors 6
Totale 13.751
Categoria #
all - tutte 37.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.287


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022475 23 25 57 26 20 50 17 26 51 40 39 101
2022/20231.082 73 102 109 124 98 134 27 140 128 37 61 49
2023/20241.154 69 88 94 92 98 108 169 109 21 70 141 95
2024/20252.602 95 83 150 209 254 225 198 202 326 353 249 258
2025/20266.694 573 423 680 629 505 530 799 256 605 713 632 349
Totale 13.751